OraLiva is a biotechnology company focused on developing diagnostic tools for oral cancer and precancerous conditions. Its work centers on cytology-based analysis of oral cell samples, using automated and data-driven methods to support clinical assessment. The company’s approach aims to improve accuracy and consistency in detecting abnormal